Ironwood Pharmaceuticals (IRWD) Increases Stock Award Pool to 26M Shares
The company raised its equity incentive plan's share reserve by 10 million shares, approved by stockholders in June.
By the FiledFeed automated desk
This summary was generated by AI from the company's SEC filing and may contain errors — always verify against the primary source on SEC.gov.
The short version
Ironwood Pharmaceuticals increased the total share reserve available for employee stock awards from 16 million to 26 million shares under its 2019 Equity Incentive Plan. The amendment was adopted by the board on March 10, 2026, and approved by stockholders on June 16, 2026.
Filing impact
Filing sentiment
Ironwood Pharmaceuticals has expanded its employee stock award program by raising the total number of shares available under its equity incentive plan.
The company increased the share reserve in its 2019 Equity Incentive Plan from 16 million shares to 26 million shares, according to the filing. This is a 10 million share increase.
The board of directors adopted the amendment on March 10, 2026. Stockholders voted to approve it on June 16, 2026, and the company filed the amendment with the SEC on June 18, 2026.
An equity incentive plan allows a company to grant stock awards, stock options, and other equity compensation to employees and executives. The larger share pool gives the company more flexibility to attract and retain talent through stock-based compensation.
Why it matters
A larger equity award pool typically signals that a company expects to use more stock compensation in the future, whether to attract new talent, retain existing employees, or fund executive incentives. For investors, this can mean potential dilution to existing shareholders' ownership stakes if the company fully uses the expanded pool. The increase from 16 million to 26 million shares suggests management believes the original authorization was insufficient for its talent and retention needs.
Frequently asked
- How many shares did Ironwood Pharmaceuticals add to its equity plan?
- The company increased the share reserve from 16 million to 26 million shares, adding 10 million shares to the 2019 Equity Incentive Plan.
- When did stockholders approve this amendment?
- Stockholders approved the amendment on June 16, 2026. The board had adopted it earlier, on March 10, 2026.
- What is an equity incentive plan?
- An equity incentive plan allows a company to grant stock awards, stock options, and other equity compensation to employees and executives as part of their compensation package.
What the filing reported
- 5.02 Departure/Election of Directors or Officers
- 5.07 Other reported item
- 9.01 Financial Statements & Exhibits
Source
Based on IRONWOOD PHARMACEUTICALS INC's 8-K filed with the SEC on Jun 18, 2026. Read the original filing on SEC.gov ↗